Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Provides significant resources to build on diversified portfolio of established and rare disease medicines

Egham, UK – 12 December 2024 – Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, today announces the completion of a €900 million financing, through a Gyrus Capital single-asset Continuation Vehicle led by AlpInvest, a subsidiary of Carlyle Global Investment Solutions, and a new strategic financing facility with Sixth Street.  

Essential Pharma was acquired in 2019 by Gyrus Capital, who have supported the transformation of the Company into a global, high-growth specialty pharma group with significant development opportunities. The transaction will enable Essential to deploy additional capital to build on its diversified portfolio and late-stage pipeline across established and rare disease medicines. This will be achieved through its successful acquisition and development strategy under the leadership of CEO, Emma Johnson. This additional capital will support Essential’s mission to ensure access to essential medicines for patients across new and existing markets. Since her appointment in 2023, Emma has driven the Company’s expansion into rare diseases, with the addition of marketed product Colobreathe® and Hu14.18, an immunotherapy in late-stage clinical development for the treatment of high-risk neuroblastoma.

Following the transaction, Lee Morley, appointed as Non-Executive Director to the Board in 2023, will assume the role of Chairman of Essential Pharma, succeeding Dr Patrick Vink. Lee has more than 30 years’ experience in the biopharmaceutical industry, with extensive knowledge of commercialisation, pricing, reimbursement and product launch strategy. He was a co-founder and CEO at EUSA Pharma before the company’s €750 million acquisition by Recordati (BIT: REC) in 2022. During his time at EUSA Pharma, he led the company’s transition from specialty pharma to oncology and rare disease, driving sales from €20 million to €150 million.

Emma Johnson, CEO of Essential Pharma, commented: “This transaction provides us with substantial additional firepower, strengthening our ability to deliver essential medicines to patients who need them most. By moving into new geographical markets and building on our diversified portfolio and late-stage pipeline across our key therapeutic areas, we can expand our reach to help underserved patient populations across the globe. We are excited to continue our relationship with Gyrus Capital as we execute our strategy to become a leading, global specialty pharma group with a growing rare disease presence, where patient needs are often most acute. As we transition to our new ownership, I’d also like to thank Patrick for his significant contributions as Chairman and welcome Lee as he steps into the role.”

Dr Robert Watson, Managing Partner at Gyrus Capital, said: “This is a landmark investment for Essential and for Gyrus Capital. We are delighted to partner with AlpInvest, Stepstone, Sixth Street and other significant private capital institutions, who believe in our shared vision of building an exceptional specialty pharma company, and bringing critical medical products to patients across the globe.”

Sixth Street, a leading global investment firm with deep experience supporting biotech companies across all stages of growth, is providing a new strategic financing facility consisting of €300 million in structured equity and growth debt.

Jeff Pootoolal, Partner at Sixth Street who will join the board of Essential Pharma, said: “Essential Pharma has assembled a leading team and platform in its pursuit of providing patients around the world with critical medicines. We are excited to support Emma and Essential’s leadership as they continue to execute and expand on their mission.”

About Essential Pharma

Essential Pharma is an international specialty pharmaceutical group dedicated to maintaining access to clinically differentiated, niche, branded medicines across multiple therapeutic areas. The group has been an important and valued partner to healthcare providers for over 20 years by giving underserved patient populations access to medicines that otherwise might not be available, and addressing clinical unmet needs. Essential Pharma operates globally in more than 70 countries, supplying a portfolio of products with a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease. The group’s growth strategy is centred on portfolio optimisation and a targeted M&A approach to acquire commercial and late-clinical stage assets in the four therapeutic areas of focus. It is a trusted partner to multiple pharma companies of all sizes, with a proven history of integrating assets and managing complex technology transfers seamlessly while ensuring continuous supply to patients.

For more information, please visit essentialpharmagroup.com

About Gyrus Capital

Gyrus Capital is a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors. Based in Geneva, Switzerland, Gyrus invests in businesses that address the structural needs of society and the environment and are positioned for long-term sustainable growth. The firm focuses on complex transactions, particularly corporate carve-outs in the €50 million to €500 million range. A renowned group of experienced partners and industry experts supports Gyrus’s active investment and value-creation approach, working closely with entrepreneurs and managers. To learn more, please visit www.gyruscapital.com

About Sixth Street

Sixth Street is a global investment firm with over $80 billion in assets under management and committed capital. Sixth Street uses its long-term flexible capital, data-enabled capabilities, and One Team culture to develop themes and offer solutions to companies across all stages of growth. Sixth Street Healthcare and Life Sciences finances the development and commercialization of innovative therapeutics and invests in healthcare technology companies across all stages of growth. Investments in the sector include Apellis Pharmaceuticals, Arrowhead Pharmaceuticals, Arsenal Biosciences, Biohaven, Blueprint Medicines, Caris Life Sciences, Chroma Medicine, ConcertAI, Datavant, Immunogen, Ironwood, and Mammoth Biosciences, among many others. Founded in 2009, Sixth Street has more than 650 team members including over 250 investment professionals operating around the world. For more information, visit www.sixthstreet.com, or follow Sixth Street on LinkedIn.

CONTACTS

Essential Pharma

Emma Johnson, CEO

Tel: +44(0)1784 477 167

Email: info@essentialpharmaceuticals.com

ICR Healthcare

Tracy Cheung/Sukaina Virji/Isabelle Abdou

Tel: +44 (0) 20 3709 5700

Email: Essentialpharma@icrhealthcare.com


Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street


THỦ THUẬT HAY

Thay đổi giao diện nghe nhạc màn hình khóa thêm độc đáo hơn

Để đổi giao diện phát nhạc trên màn hình khóa iPhone, chúng ta có thể cài đặt tweak SpinXI mà Quản trị mạng đã từng hướng dẫn tới bạn đọc. Và trong bài viết này chúng tôi sẽ giới thiệu thêm tweak ColorFlow 4. Tinh

9 ứng dụng dành cho Android đang miễn phí và giảm giá

Hiện tại, trên cửa hàng Google Play đang cho phép người dùng tải về miễn phí 9 ứng dụng và trò chơi bản quyền khá hay. Nếu đang sở hữu một chiếc Android phone thì mời bạn cùng xem và nhanh tay chọn lựa cho mình một vài

Cách sử dụng sổ liên lạc VnEdu để tra cứu thông tin học sinh

VnEdu giúp quản lý thông tin giáo dục từ trường học cho đến các cấp quản lý, đồng thời cũng giúp kết nối thông tin giữa gia đình và nhà trường, giúp nâng cao chất lượng quản lý, dạy và học hiện nay. Mạng giáo dục Việt

Cách lấy lại mật khẩu Facebook bị mất bằng email hoặc số điện thoại

Nếu bạn quên mật khẩu Facebook nhưng vẫn duy trì được tình trạng đăng nhập trên 1 thiết bị nào đó mà không nhớ email hoặc số điện thoại thì cách giải quyết vấn đề đơn giản hơn rất nhiều.

Ứng dụng cảnh báo điểm ngập miễn phí ở Hà Nội

Nó có tính năng chính là cung cấp thông tin hiện trạng của các trạm đo mưa, đo điểm ngập trên địa bàn Hà Nội, bên cạnh đó còn có hệ thống bản đồ tìm đường đi để tránh các điểm mưa ngập. Người sử dụng cũng có thể gửi

ĐÁNH GIÁ NHANH

Đánh giá sạc nhanh trên A9 Pro: Sạc 2 giờ 40 phút để làm đầy viên pin 5.000 mAh

Samsung Galaxy A9 Pro, được trang bị viên pin lớn 5.000 mAh, tích hợp công nghệ sạc nhanh Quick Charge 2.0, rút ngắn thời gian sạc xuống chỉ còn 2 giờ 40 phút

So sánh thời gian sử dụng pin Xperia XA1 Plus với các đối thủ cùng phân khúc

Dẫn đầu cuộc đua lần này thuộc về Vivo V7+ khi máy có thời lượng sử dụng pin lâu nhất (15.5 tiếng), tuy nhiên sản phẩm này chỉ có màn hình HD mà thôi (màn HD sử dụng ít điện năng hơn màn hình Full HD).

So sánh Vivo Y21 và Vivo Y21s: Chênh nhau 1 triệu đồng nên chọn smartphone nào?

Vivo chỉ mới ra mắt Y21 cách đây không lâu và giờ tiếp tục lại ra mắt thêm Y21s. Giữa hai mẫu điện thoại này có điểm gì giống và khác nhau, nên mua điện thoại nào? Hãy cùng mình so sánh Vivo Y21 và Vivo Y21s để tìm đáp